Skip to main content
Navigate Up
Sign In

Clinical Trials Search

If you are a researcher seeking volunteers and your study is not posted, please submit your Web ad here.

SEARCH

Search Again

 Results From Research and Clinical Trials : Selected site
TitleStudy GoalsEligibility CriteriaContact Information
Diabetic Male and Female Volunteers Needed for Exercise Research Study 06-0062
Evaluate exercise function during single leg calf exercise in people with or without type 2 diabetes
Healthy Adults 30-70 with Type 2 diabetes but not using insulin. Must be a non-smoker who exercise no more than one time per week and have a BMI of 25-40
PI: Regensteiner, Judith
  • 303-724-2255
  • Deirdre.rafferty@ucdenver.edu
Trouble Controlling your Type 2 Diabetes? 12-1529
Investigational non-surgical device that may help decrease blood sugar.
Adults 21-65 with type 2 Diabetes and not on oral medication, not taking insulin. Must have an A1C level of 8-10%, be overweight or obese and willing to attend study visits
PI: Wyatt, Holly
  • GI Dynamics
  • Jeanneanne.breen@ucdenver.edu
Project Safe - THE IMPACT OF MEDICAL MARIJUANA IN METROPOLITAN DENVER 11-0718
To learn more about the medical marijuana industry in Colorado and its relationship to health risk behaviors and healthcare.
Persons 18+ currently a medical marijuana patient or currently using non-medical marijuana
PI: Booth, Robert
  • 1-800-429-9240
  • Eric.Kovalsky@ucdenver.edu
Persons with active, moderate to severe ulcerative colitis needed 12-1408
This study is being conducted to investigate the efficacy of methotrexate in treating ulcerative colitis in patients that have active, moderate to severe colitis and have failed other types of therapies.
Inclusion: Ages 18-70 Ulcerative colitis has been diagnoses by routine criteria At least one of the following applies: steroid dependent failed 5-ASA (mesalamine) therapy, such as Asacol Failed/lost response to infliximab (Remicade) Intolerant/unresponsive to azathioprine (Imuran) or 6-MP (purinethol) therapy Exclusion (partial): Existing pregnancy, lactation, or planned pregnancy (men and women)
PI: Gerich, Mark
  • 303-724-7875
  • katelyn.cowan@ucdenver.edu
Have the Flu? Living with a chronic medical condition, too? 11-0101
Influenza (the flu) can be life-threatening. Approximately 24,000 people in the United States die each year of this disease. We are conducting a study to determine whether treating patients with a combination of several drugs instead of just one helps them to get better faster.
You qualify for our study if you: •Have been diagnosed with the flu •Are at least 18 years of age •Have an existing medical condition that puts you at increased risk for complications from the flu—conditions such as diabetes; heart, lung, and kidney disease; COPD; and asthma
PI: Barron, Michelle
  • 303-724-0712
  • Graham.Ray@ucdenver.edu
Healthy Postmenopausal Women Needed for Cardiovascular Research Study 14-0532
The purpose of this study is to investigate how the health and function of arteries respond to estrogen, resveratrol, and exercise.
Postmenopausal women between the ages of 50-70 years, nonsmokers, not currently taking hormone replacement therapy or exercising vigorously more than 2 days per week.
PI: Moreau, Kerrie
  • 303-724-7465
  • cemal.ozemek@ucdenver.edu
Do you or someone you know have a food allergy to soy? 14-0097
We are studying the accuracy of a food allergy blood test.  
-Are age 1 to 21 and -Do have an IgE level greater than 0.35 to wheat OR soy or -Have had a positive skin test to wheat OR soy or -Have a clinically diagnosed wheat OR soy allergy -Do NOT use >500 micrograms/day fluticasone or equivalent -Do NOT have severe asthma, daily oral steroid dosing, or asthma requiring hospitalization within a year or an ER visit in the past 6 months -Do NOT have active EoE (or recently diagnosed) -Have NOT used biologic or allergen immunotherapy within the past year
PI: Fleischer, David
  • 720-777-2569
  • Hannah.Gilbert@childrenscolorado.org
Participants Needed For Research on Military Veterans And Service Dogs 14-2041
The purpose of this study is to explore the relationship between military veterans and their service dogs. Veterans will participate in one on one interviews.
Are you a military veteran? Do you have a service dog? Are you 18-89 years old? If you answered yes to the above, contact C-P.A.W.W. today.
PI: Krause-Parello, Cheryl
  • (303)-724-8282
  • CPAWW@ucdenver.edu
Do you have HIV and lipodystrophy? 14-1595
Our research aims to determine whether the development of Lipodystrophy Syndrome is related to changes in the types of bacteria that live in the gut (stool) that occur in HIV-infected individuals.
Non-obese HIV-positive people who are 18-70 years old. Exhibiting the symptoms described above, indicating the possibility of lipodystrophy.
PI: Lozupone, PhD, Catherine
  • 303-724-0762
  • christine.griesmer@ucdenver.edu
Type 1 Diabetes Research Study 15-1309
The purpose of this research study is to evaluate the effects of an FDA-approved medication (bromocriptine QR) on insulin dosing, glucose control, and blood vessel function.
Persons 18-60 with Type 1 Diabetes, Non-smokers
PI: Schauer, Irene
  • 7208486690
  • ellen.lyon@ucdenver.edu
We are looking for MEN who have not been diagnosed with cancer to participate in a research study. 11-0357
A comparison of immune function from unaffected individuals for the study of tumor-induced immune suppression
To participate you must: -Older than 18 -Be willing to make a one-time blood donation -Not be diagnosed with an immune disease such as diabetes,hepatitis or rheumatoid arthritis You could make a difference in the future of men!
PI: Borges, Virginia
  • 303-724-6077
  • emily.rozzo@ucdenver.edu
Participants needed for a Balance and Fall-Risk Research Study for People with Multiple Sclerosis 15-1806
This study involves balance and head movement testing aimed at predicting risk of falls
Are between the ages of 30 and 60 years
• have MS
• are able to turn your head at least 30 degrees to the left,
• have experienced a fall in the last 3 months
PI: Hebert, Jeffrey
  • 303-724-4717
  • molly.strobel@ucdenver.edu
Healthy Adults Needed for Clinical Research Study 15-1643
The purpose of this study is to learn about the effects (good and bad) of interferon-gamma 1b (IFN-γ 1B) has on the body's immune cells when given to healthy adults.
Ages ≥ 18 to 60 years old Has not received IFN-γ within the last 30 days of study enrollment At the time of screening, deemed healthy by the Principal Investigator with no active infections and is not currently receiving medications for an infection No diagnosis of chronic health conditions or is on long-term medications for that condition Women of childbearing potential must have a negative pregnancy test to qualify and agree to two forms of effective contraception for the duration of the study (plus one month afterward)
PI: Ambruso, Daniel
  • 303-324-2171
  • daniel.ambruso@ucdenver.edu
Volunteers Needed for blood donation for research and development. WIRB 20110239
To gain knowledge relating to the collection, storage and product modifications of whole blood, apheresis units, and various blood components as well as the function and biochemistry of various types of blood cells.
YOU MAY QUALIFY TO DONATE IF YOU: -Are at least 18 years old -Weigh 110 pounds or more -Are in good general health -Can attend appointment(s) during the week
PI: Le, Tuan
  • 303-363-2300
  • Lisa_Sherritt@Bonfils.org
Apoyo con Cariño: Improving Palliative Care for Latinos with Cancer 12-0592
We want to understand if a patient navigator can help Latino patients and their family caregivers deal with cancer. Our project hopes to improve palliative or comfort care to patients with advanced cancer. The goal is to prevent or relieve suffering for people facing serious illness. Research is needed to find out if a patient navigator can help patients and family caregivers.
Adults (18 years and older) who self-identify as Latino and have Stage III-IV cancer.
PI: Fischer MD, Stacy
  • 303-724-7410
  • danielle.kline@ucdenver.edu
SPIROMICS-Subpopulations and Intermediate Outcome Measures in COPD Study HS-2678
To identify subpopulations of COPD patients in order to develop newer and more effective treatments and to clearly define measureable end points so that treatment effects may be accurately assessed in a shorter period of time.
Be willing to undergo study procedures Be between the age of 40 and 80 years old Have smoked fewer than one pack of cigarettes per day for one year OR have smoked more than one pack of cigarettes per day for 20 years
PI: Bowler, Russell
  • 303-270-2827
  • HerrudT@njHealth.org
Healthy Female Adolescents Needed!!! 07-0816
For brain imaging research study on how the brain works with we taste sweets or receive money. Your participation could help us to develop treatments and preventive measures for anorexia nervosa and obesity
Healthy females 11 to 21 who are right-handed, free of medication with no serious medical conditions, permanent metal implants or braces/retainers, and are at a healthy body weight.
PI: Frank, Guido
  • 720-777-4026
  • imaging.research@childrenscolorado.org
A Study to Determine the Effectiveness of Seeing Dermatologist Online Compared to In-Person 14-0585
The purpose of the study is to see whether seeing a dermatologist online is just as effective as seeing one in-person. Help us determine whether online-based model is cost-saving and more efficient compared to face-to-face visits!
In order to qualify for the study, you must be 18 years or older and have psoriasis. You must have access to the internet, and a digital camera or a mobile phone with a camera.
PI: Dunnick, Cory
  • 720-848-3607
  • psoriasiscolorado@ucdenver.edu
Do You or Someone You Care for Suffer from Troublesome Drooling? 13-2237
A research study is being conducted to evaluate an investigational product for Sialorrhea (troublesome drooling).
You or your loved one may be eligible to participate if you meet the following criteria: 1. Have a diagnosis of Parkinson’s disease, adult cerebral palsy, ALS, stroke, traumatic brain injury, oral cancer, or side effects of medication, or any other condition that causes Sialorrhea or troublesome drooling 2. Have never received any type of treatment using Botulinum toxin type B 3. Have ability & availability to participate in a study for up to 1 year
PI: Klepitskaya, Olga
  • 303-724-8305
  • kalie.petefish@ucdenver.edu
Parkinson's Disease Research Study 14-0879
clinical research study to look at the safety and effectiveness of an investigational medication, ADS-5102 (amantadine HCl) extended release capsules, for troublesome dyskinesia in subjects with Parkinson’s disease.
You may be eligible if you have Parkinson's Disease, currently take levodopa, and are experiencing troublesome dyskinesia (involuntary twisting and turning).
PI: Leehey, Maureen
  • 303-724-8305
  • Kalie.Petefish@ucdenver.edu
Type 2 Diabetes Medication Research Study 13-2015
Studying the effects of sitagliptin (a diabetes medication) on exercise capacity in people with type 2 diabetes
-Be a man or woman between 22 and 70 years old -Be generally healthy, with type 2 diabetes -Be taking metformin only for your diabetes -Be a non-smoker -Have a Body Mass Index greater than 25.0
PI: Regensteiner, Judith
  • 303-724-2255
  • Deirdre.rafferty@ucdenver.edu
Research study to investigate how therapies work to reduce tension-type headache 14-1582
To understand how massage or ultrasound therapies affect blood flow within myofascial trigger points that are related to chronic pain such as tension-type headache.
Persons aged 21-49 who experience chronic or episodic tension-type headache and are not currently receiving massage, ultrasound, trigger point injection, or needling therapies.
PI: Moraska, Albert
  • 303-819-1834
  • albert.moraska@ucdenver.edu
" EDEN "Estrogen, Diabetes and Endothelial Function 10-0591
Study the effect of estrogen on blood vessels
CONTROL PARTICIPANT ELIGIBILITY  Age 18-45  Premenopausal  Not using hormonal birth control currently or in the last 6 months (including oral contraceptives, contraceptive patch, Depo Provera, norplant, or IUD)  Not currently pregnant or planning to become pregnant in the next 3 months  No recent history of amenorrhea (no menstrual period for at least 3 months) during the last 6 months  Non-smoker  No antioxidant therapy (vitamin C or E or multivitamin) for at least 4 weeks prior to the firststudy visit Normal thyroid function (can be treated) T1D ELIGIBILITY  Age 18-45  Premenopausal  Have had type 1 diabetes for at least 5 years, were treated with insulin within a year of diagnosis, and are currently treated with insulin  Not using hormonal birth control currently or in the last 6 months (including oral contraceptives, contraceptive patch, Depo Provera, norplant, or IUD)  Not currently pregnant or planning to become pregnant in the next 3 months  No recent history of amenorrhea (no menstrual period for at least 3 months) during the last 6months  Non-smoker  No antioxidant therapy (vitamin C or E or multivitamin) for at least 4 weeks prior to the first study visit HbA1c < 9.5 Normal kidney function (urinary albumin excretion rate < 200 µg/min) Normal thyroid function (can be treated)
PI: Snell-Bergeon, Janet
  • 303-724-8351
  • Perla.Rodriguez@ucdenver.edu
We are looking for Healthy Women to participate in a research study on.....Females, Aging, Metabolism, and Exercise (FAME) 12-1157
To examine the role that female sex hormones play in metabolism, energy expenditure, physical activity and chronic disease.
Healthy women 40-60 who have regular menstrual cycles and using no hormonal contraceptives
PI: Kohrt, Wendy
  • 720-848-6399
  • FAMEStudy@ucdenver.edu
Do you have Diabetes? 13-0131
To find the best combination drug treatment for type 2 diabetes
Persons who have had diabetes for less than 5 years and metformin is the only diabetes medication you are taking.
PI: Rasouli, Neda
  • 720-848-7174
  • Bradley.wine@ucdenver.edu
Type 1 Diabetes Research Study 11-0693
To study the effects of an FDA-approved medication on metabolism and blood vessel function.
Person 25-50 with type 1 diabetes who exercise vigorously less than four times per week and have normal blood pressure
PI: Schauer, Irene
  • 720-848-6690
  • Ellen.Lyon@ucdenver.edu
CHILDHOOD and ADOLESCENT MIGRAINE PREVENTION STUDY 12-0776
to test two medicines for migraine prevention in children and teens. We want to see if amitriptyline and/or topiramate are better than placebo (sugar pill) in reducing headache frequency.
Children 8-17 who have migraine headaches
PI: Kedia, Sita
  • 720-777-8588
  • headacheresearch@childrenscolorado.org
Just received VARIVAX, the chickenpox vaccine? 13-2122
Research study looking at the immune response to chickenpox vaccine
Age 12 months to 50 years; able to enroll in study within 10 days of vaccination.
PI: Levin, Myron
  • 303/724-2454
  • nancy.lang@ucdenver.edu
Healthy Women Needed for Cardiovascular Research Study 06-0537
The purpose of this study is to investigate how the menopause transition and the loss of estrogen impacts the health and function of arteries in women.
- Premenopausal women 18-49 years, Perimenopausal women 40-55 years and Postmenopausal women 45-70 years - Non-smokers - Volunteers should NOT be taking Birth Control or Hormone Replacement Therapy (HRT) or exercising vigorously more than 2 days per week.
PI: Moreau, Kerrie
  • 720-848-6419
  • shape.study@ucdenver.edu
Healthy Hispanic Female Needed 07-0816
For brain imaging research study on how the brain works with we taste sweets. Your participation could help us to develop treatments and preventive measures for anorexia nervosa and obesity
Healthy females 22 to 29 who are right-handed, free of medication with no serious medical conditions, permanent metal implants or braces/retainers, and are at a healthy body weight.
PI: Frank, Guido
  • 720-777-4026
  • imaging.research@childrenscolorado.org
Looking for HIV-positive individuals to participate in a research study on Lipodystrophy Syndrome 14-1595
We are conducting a study of the relationship of bacteria in the gut to HIV infection. We are interested in finding out whether people who have metabolic diseases such as lipodystrophy (loss of fat tissue) as complications of long term antiretroviral therapy have a different makeup of their gut bacteria. We are therefore seeking volunteers with HIV infection to participate in a study of bacteria in the stool.
-Non-obese HIV positive individuals who are 18-65 years old -Either not currently on antiretroviral therapy (ART naïve or off therapy for 6 months or greater) or on effective ART with documented suppression for 6 months or greater. -We are particularly interested in enrolling subjects with lipodystrophy, but would also like to enroll individuals without lipodystrophy as controls.
PI: Lozupone, PhD, Catherine
  • 303-724-0762
  • christine.griesmer@ucdenver.edu
Looking for HIV-positive and HIV-negative men to participate in a research study on smoking and lung disease 13-2986
We are conducting a study to look at lung complications and disease in HIV/AIDS.
-Between 30 and 70 years old -Both HIV-positive and HIV-negative individuals with and without chronic obstructive pulmonary disease (COPD) -If HIV-positive, on a stable three-drug ART regimen with undetectable viral load for past 6 months
PI: Campbell, MD, Thomas
  • 303-724-0762
  • christine.griesmer@ucdenver.edu
GENETIC-AF 14-0736
The GENETIC-AF is a trial that will investigate the safety and effectiveness of an investigational drug on the recurrence of symptomatic atrial fibrillation in people who have heart failure. The investigational drug will be studied versus an approved drug after patients receive an electrical cardioversion.
Adults who have symptomatic atrial fibrillation may be eligible.
PI: Aleong, Ryan
  • 303-724-8277
  • Christina.schmitt@ucdenver.edu
Healthy Volunteers Needed 10-1311
To examine the differences in two subtypes of Parkinson Disease compared to health controls. This study involves an MRI.
- Between the ages of 50-80 - No metal in your body - In general good health
PI: Berman, Brian
  • 303-724-5865
  • erika.shelton@ucdenver.edu
WISH - Women, insulin and sex hormones. Premenopausal women with type 1 diabetes needed for a research study. 10-0591
This study plans to learn more about the menstrual cycle in women with Type 1 diabetes compared to the women who do not have diabetes. In addition, this research study plans to learn about the relationship between reproductive hormone levels and early signs of heart disease and hardening of the arteries in women with Type 1diabetes.
Age 18-45 Premenopausal Not using hormonal birth control and planning to stay off of them for at least 3 months. No currently pregnant or planning to become pregnant in the next 3 months. No recent history of amenorrhea (no menstrual period for at least 3 months) during the last 6 months. Menstrual cycle between 25-35 days on average. Normal thyroid function (can be treated) Normal kidney function (urinary albumin excretion rate
PI: Snell-Bergeon, Janet
  • 303.724-8351- Perla Rodriguez
  • Perla.Rodriguez@ucdenver.edu
Cognitive Dysfunction in Parkinson's Disease 10-0771
This research study plans to use simultaneous brain scans and memory tasks to see if stimulating certain areas of the brain improves thinking and memory. This is not a treatment study
Healthy males over 50 with Parkinson's disease on stable doses of medication and have no metal in the body (dental work may be ok).
PI: Kluger, Benzi
  • 303-724-5973
  • isabelle.buard@ucdenver.edu
EFFECTS OF TESTOSTERONE THERAPY IN YOUNG ADOLESCENTS WITH KLINEFELTER SNDROME (47.XXY) 11-0874
This study will study the effects of testosterone therapy on behavior, mood, problem solving, attention span, and motor skills in adolescent males with Klinefelter syndrome in early puberty. During this period in early puberty there is a lot of variability in how and when doctors start testosterone therapy. This study will evaluate if there are benefits to starting testosterone therapy in early puberty.
Participants with Klinefelter syndrome in early puberty (around age 10-15).
PI: Tartaglia, Nicole
  • 720-777-8361
  • susan.howell@childrenscolorado.org
Volunteers with Alzheimer’s Disease Needed for Memory Study 12-1273
To examine the safety and efficacy of the study drug, Sargramostim (Leukine®), on memory in adults with Mild-to-Moderate Alzheimer’s Disease.
1. Age 55 to 85 years; 2. Should have a mild-to-moderate Alzheimer's Disease diagnosis (Mini-Mental State Examination 10-26 inclusive); 3. If on anti-dementia treatment should be on stable treatment for at least 2 months (i.e. cholinesterase inhibitor and/or Memantine or Axona); 4. Stable on all other medications for at least 30 days prior to screen; 5. Should be fluent in English; 6. Should be physically able to participate by medical history, clinical exam and tests; 7. Should have a study partner to accompany them to scheduled visits.
PI: Potter, Huntington
  • 303-724-2997
  • joseph.daniels@ucdenver.edu
Do you have high blood pressure? 13-3174
Researchers at the University of Colorado Hospital are conducting a research study to help predict if blood pressure medications will work for you.
Subject must be between 30 and 75 years of age and have a diagnosis of uncontrolled hypertension (high blood pressure).  As part of the study, you may be eligible for free medication and free clinic visits to check your blood pressure
PI: Monte, Andrew
  • 303-724-7871
  • Oghenero.Evero@ucdenver.edu
T•A•C•I•T - Therapy After Cochlear Implants Using Telemedicine 12-1103
This research plans to learn more about the use of telemedicine as a means of providing therapy to children who have a cochlear implant(s). While Auditory-Verbal Therapy has typically been delivered in person, many people are starting to access therapy over the internet. We are conducting this research to determine if the outcomes of therapy are the same when AVT is delivered in person and via telemedicine.
The TA•C•I•T team is looking for children ages 6 mos.-6 yrs. old who were implanted with cochlear implant(s) before age  3 ½..  Each child will spend nine months in both the in-person and telemedicine condition. The therapist will remain the same throughout the study. Total participation will last 18 months. The child will be tested three times: once when the study starts, and every nine months after that. A qualified study team member will administer speech, listening, and language tests to the child. They will also receive tests to identify how well their auditory area of the brain is developing.
PI: Grigsby, Jim
  • 303.556.5804
  • tacit@ucdenver.edu
Participants with Chronic Kidney Disease Needed for a Research Study about Phosphate 13-0328
We are looking for men and women to participate in a research study examining whether lowering blood levels of phosphate will improve blood vessel function.
We need men and women who:  -are age 40-79 years old; women must be post-menopausal;  -have chronic kidney disease stage 3b or 4 (estimated GFR 15-45 ml/min);  -are not taking phosphate binders;  -do not have high blood phosphate (>5.5 mg/dL).
PI: Jovanovich, Anna
  • 303-724-7790
  • mikaela.malaczewski@ucdenver.edu
ESS-NSPAS Study 14-1808
Bayer HealthCare is sponsoring a medical research study to look at the effectiveness of Essure after having a procedure (NovaSure) that decreases your heavy menstrual bleeding. Both Essure and NovaSure are approved by the FDA. This study is enrolling patients now and you may qualify to participate.
Are you currently using the Essure method of contraception? Are your periods heavy, frequent or prolonged? One important prerequisite is - you must have had a successful Essure placement AND be willing to undergo a NovaSure endometrial ablation, a treatment option for heavy menstrual bleeding (menorrhagia).
PI: Tocce, Kristina
  • 303-724-5559
  • christina.gavito@ucdenver.edu
Volunteers Needed for Cardiovascular Research Study at the Division of Renal Diseases and Hypertension Clinical Research Unit 15-0869
This research study will compare blood vessel function in healthy adults to adults with two different types of kidney disease. The testing visit will include non-invasive testing of blood vessel function and collection of blood and cells from an IV. As a volunteer, you will receive the following information about your health:resting EKG; blood cholesterol screening, blood sugar screening, blood pressure screening, and physical Exam.
We are looking for men and women, aged 18-80 years, non-smokers, generally healthy, and free from hypertension. Women must not be pregnant of trying to become pregnant
PI: Nowak, Kristen
  • 303) 724-9508
  • Laurel.Thur@ucdenver.edu
Volunteers are Invited for a Research Study Looking at Pain in Knee Osteoarthritis 12-1188
- To better understand the complex experience of pain for people with knee osteoarthritis - This study will measure different aspects of pain perception and knee function in people with and without knee osteoarthritis
- Age 50-85 - NOT diagnosed with knee osteoarthritis - NO knee pain
PI: Stevens-Lapsley, Jennifer
  • 303-724-9590
  • kneepain@ucdenver.edu
Research Study: "Anxiety Risk in Teens" 12-0424
To learn more about risk factors for anxiety in adolescents with cyclic vomiting syndrome.
Adolescents 13-18 who have been diagnosed with either an anxiety disorder or cyclic vomiting syndrome
PI: Tarbell, Sally
  • 720-777-6255
  • sally.tarbell@ucdenver.edu
Are you interested in learning about how your breast milk helps your baby grow? 12-0629
To find out how maternal size and diabetes status affect her breast milk To find out what unique parts of breast milk may affect how infants grow. To learn how to ensure infants receive the best nutrition possible
Women 20-35 who are at least 28 weeks into their pregnancy and planning on exclusively breastfeeding their infant for at least 4 months and delivering at University of Colorado Hospital.
PI: Krebs, Nancy
  • 303-724-3972
  • catherine.chartier-logan@ucdenver.edu
Free Family Therapy for Youth with Mood Problems 11-1048
Helping youth and their families understand and cope with mood swings, develop plans for preventing moods from getting worse, communicate more effectively and solve family problems
  • Youth between 9-17 who has recently had significant mood swings, has at least one parent with bipolar disorder and does not abuse alcohol or substances. 
  • Must agree not to participate in family therapy with another provider for the first year.
PI: Schneck, Christopher
  • 303-492-1668
  • Anna.Frye@colorado.edu
Genital Herpes? 13-2122
This study will look at the body's immune response (how the body fights infection) to the onset of genital herpes.  1-2 study visits for blood draws over the course of 3 months.
  • 18+ years of age
  • Have developed an outbreak of genital herpes within the last 10 days.
PI: Levin, Myron
  • 303/724-2454
  • nancy.lang@ucdenver.edu
Pregnant Participants Needed: 13-3019
Pregnant women are invited to participate in a research study which plans to learn about antibody (substance produced by the body to fight disease) levels in mothers and infants whose mothers have received the GBS vaccine between 24-34 6/7 weeks of their current pregnancy.  the study will also look at antibody levels in mother's breast milk.
  • Healthy pregnant woman 18-40 years of age 24 0/7 through 34 6/7 weeks pregnant 
  • Planning to breastfeed for at least 90 days after delivery 
  • Plan to deliver at University of Colorado Hospital
PI: Gibbs MD, Ronald
  • 303-724-2005
  • sarah.schwartz@ucdenver.edu
Healthy Males needed for a research study of drug levels in blood and hair. 13-0427
This study plans to learn more about how tenofovir and emtricitabine (Truvada) build up in cells in blood and hair. Participation will include two 12 week dosing periods separated by a 12 week washout period (total duration is 36 weeks). Eligible participants will be given the supply of medications for the study.
  • Must be age 18 to 50 years
  • Must own smartphone
  • Subject has a minimum scalp hair length of 2 cm in the occipital region.
  • Have a low risk for HIV-1 infection
PI: Anderson, Peter
  • 3037248296
  • kayla.bushman@ucdenver.edu
The Role of Gut Bacteria in the Development of Type 1 Diabetes. 11-1144
The goal of the research is to better understand the role bacteria that live in the intestine in the development of type 1 diabetes
  • Patients diagnosed with type 1 diabetes in the last 6 months 
  • Subjects with islet autoantibodies 
  • Subjects who do not have islet antibodies and are first-degree relatives of patients with diabetes or subjects with islet antibodies
  • 1-45 years of age
PI: Zipris, Danny
  • 303-724-6820 or 303-724-6821
  • aimon.alkanani@ucdenver.edu or james.needell@ucdenver.edu
Are you interested in participating in a research study to help us learn more about where the fat tissue in your body originates? 13-0026
To understand if some fat cells (adipocytes) may originally come from cells in the bone marrow. Understanding the origin of fat cells is important because it may help to determine the health of fat cells and why fat that is stored in some places of your body is more ‘unhealthy’ than other fat.
Men and women: Between the ages of 18 and 75 years AND Had an allogeneic hematopoietic stem cell transplant at least 6 months ago –OR– Have chronic phase chronic myeloid leukemia.
PI: Klemm, Dwight
  • 303-724-7472
  • kathleen.gavin@ucdenver.edu
Interested in participating in a free weight loss class? 15-0989
The CU Anschutz Health and Wellness Center is seeking volunteers for a new weight loss research study looking at the role of beef intake for weight loss and weight maintenance. The study will last approximately 6 months. Participants will participate in a 16-week State of Slim weight loss program at no cost and receive monetary stipends to be used to purchase State of Slim-friendly protein foods. Participants will receive body composition scans, lab work and wellness assessments at no charge and have access to the Anschutz Health and Wellness Fitness Center during the study.
 Are between 18 - 50 years old  Are overweight or obese (BMI ≥ 27) - Check your BMI at: http://www.nhlbi.nih.gov/health/educational/lose_wt/BMI/bmicalc.htm  Are willing to participate in weekly group weight loss classes for 16 weeks and attend four study visits over a 6 month period at the Anschutz Medical Campus  Are not vegetarian  Are not diabetic  Are not allergic to red meat or other common protein sources
PI: Hill, James
  • 303-724-9198
  • hannah.k.nelson@ucdenver.edu
Tell us your story... 12-1432
To learn more about reproductive health of Latina and Hispanic women
Female Age 29-43 Born in the U.S. Both parents born in the U.S. A grandparent or great-grandparent born in Mexico OR of Hispanic origin
PI: Bull, Sheana
  • 303-916-6567
  • kate.coleman-minahan@ucdenver.edu
Are you interested in learning more about daily blood sugar changes in your child? 14-0960
The Endocrinology department at Children’s Hospital Colorado is looking for children and young adults interested in learning about day-to-day blood sugar changes. The study involves a single visit where diabetes screening will be provided as well as placement of a continuous sugar monitor to be worn for up to 7 days.
Age 10-25 years BMI < 85%ile Baseline health
PI: Chan, Christine
  • 7207774354
  • tim.vigers@childrenscolorado.org
Do you have Parkinson's Disease? 11-1237
To explore the effects of different doses of endurance exercise in people with PD.​
Persons 40-80 who have been diagnosed with Parkinson's Disease and are not yet taking medication or plant to start medication within the next 6 months. You must be willing to begin the exercise program immediately or after a delay of 6 months and willing to do aerobic exercise on a treadmill.
PI: Schenkman, Margaret
  • 720-848-6376
  • Toby.Wellington@ucdenver.edu
Do you have Atopic Dermatitis (Eczema)? HS-2581
To study eczema
Males and Females between 3 and 80 who have atopic dermatitis or males and females between 8 months and 80 who have a history of, or an active case of eczema hereticum (wide-spread herpes skin infection along with atopic dermatitis.
PI: Leung, Donald
  • 303-398-1409
  • taylorp@njhealth.org
Better Control of Type 2 Diabetes May Decrease Your Risk for Cardiovascular Disease. 10-0644
To look at the use of an extended release formula of Exenatide compared to a placebo to maintain normal glucose levels. Ultimately to see better control of diabetes and a decrease in cardiovascular disease events.​
Person 18+ with Type 2 Diabetes and take no more than 2 diabetes medications with stale doses for the last 3 months. Must not have a planned or anticipated revascularization procedure, but may have a history of cardiovascular disease and must see your primary care physician at least twice a year.
PI: Rasouli, Neda
  • 303-399-8020 X2059
  • chantal.underkofler@ucdenver.edu
Type 2 Diabetes and Exercise Research Study 10-1393
To research the effects of an investigational drug on exercise capacity and blood vessel function​.​
Person 30-60 with Type 2 diabetes who exercise vigorously less than one hour per week and have normal blood pressure. Must not have smoked for at least one year and have a BMI between 25-39.9.
PI: Schauer, Irene
  • 720-848-6690
  • Ellen.Lyon@ucdenver.edu
Are you a Non-smoking Adult between the ages of 45 and 85? HS-1883a
We are interested in learning more about smoking related lung disease, and need healthy non-smoking participants.
45-85 years old Non-Hispanic White or African American No smoking history No evidence of lung disease
PI: Bowler, Russ
  • 303-270-2566
  • FratelliC@NJHealth.org
Alterations in Lung Microbiome in Acute and Chronic HIV Infection 09-0898
This is a prospective, observational cohort study. Three groups (A1, A2, and B) will be enrolled in parallel.
-Men and women >/= 18 years. -Willing to follow all research requirements -Willing to provide written informed consent -Group A1- acute HIV infection defined as a high risk HIV exposure within the prior 30 days, or recent HIV-1 seroconversion defined as those with a high risk HIV-1 exposure -Group A2- healthy controls: HIV-1 seronegative with no high risk HIV-1 exposure in the prior 30 days and no chronic medical illness -Group B- HIV-1 infection diagnosed by a previous positive antibody or PCR test have been recommended to initiate HAART by their health care provider You should not be in this study if you are a pregnant or planning to become pregnant.
PI: Campbell, Thomas
  • 303-724-0762
  • christine.griesmer@ucdenver.edu
Volunteers needed to Participate in a Research Study about Rheumatoid Arthritis 01-675
The purpose of this study is to learn more about how rheumatoid arthritis develops by studying people who do not have rheumatoid arthritis. Your participation in this study will help us determine if certain genetic and environmental factors affect the chances of developing RA-related autoantibodies in absence of rheumatoid arthritis.
You may be eligible to participate in the study if: -You are at least 40 years old -You do NOT have Rheumatoid Arthritis (RA)
PI: Norris, Jill
  • 303-724-7510
  • Marie.Feser@ucdenver.edu
Restoring Insulin Secretion (RISE) 13-0122
The Children’s Hospital Colorado Clinical Translational Research Center and the National Institutes of Health are conducting a study. This study is aimed at testing whether early treatment is beneficial to kids with early type 2 diabetes and kids at high risk of diabetes.
10-19 years of age, Pubertal, Overweight, Fasting glucose: >90 mg/dl; Impaired glucose tolerance: >140 mg/dl; Pre-diabetes or diagnosed with diabetes for less than 6 months; Metformin
PI: Nadeau, Kristen
  • Susan Gross
  • susan.gross@childrenscolorado.edu
Do You Smoke? 12-0181
To figure out how these lung substances work in people who drink too much alcohol, who usually smoke, compared to those who do not drink heavily, but who smoke.
Smoking and nonsmoking males
PI: Burnham, Ellen
  • 303-724-6081
  • Carrie.Higgins@ucdenver.edu
Parents or Legal Guardians of Children with Disabilities 12-1664
Assistive Technology Partners, University of Colorado, Anschutz Medical Campus, is performing a study investigating the impact Socially Assistive Robotics has on motor, communication and cognitive skills of children with disabilities.
Children between the ages of 18 months to 5 years of age Have Significant motor and communication disabilities/delays NOT been diagnosed with blindness or deafness They are without a seizure disorder or with a well-controlled seizure disorder They have been on stable medication regime for the past 12 weeks, if they are currently taking medication.
PI: Sandstrum, Jim
  • 303-315-1287
  • Jim.Sandstrum@ucdenver.edu
The Influence of Couples' Conversation on the Heart 13-2188
The purpose of the study is to examine the influence that conversations between married couples have on the functioning of the heart.
Married Christian couples who: • Have been married for at least 1 yr. • Both believe in prayer. • Are not currently taking heart medications. • Do not have heart problems. • Are not pregnant.
PI: Grigsby, Megan
  • 303-556-6020
  • couplesandheartstudy@gmail.com
Help Us Learn About Schizophrenia! 12-1186
Help us learn more about a new drug that may improve thinking and concentration in people with schizophrenia.
We are looking for: Male and female adults who smoke 18-50 years old No previous or current mental illness No drug use Willing to use nicotine patch during study hospital visit If female, willing to use birth control during the study
PI: Freedman, Robert
  • 303-724-6214 or 303-724-7373
  • psypharmresearch@ucdenver.edu
Research Trial Evaluating a New Drug in Psoriasis: Now Enrolling 14-1692
The study will evaluate an investigational drug compared to a currently approved psoriasis medication. Your participation will provide valuable information to researchers seeking new and improved therapies. You will be given either Humira, placebo, or the investigational drug for up to 28 weeks, after which you may be switched over to the active drug depending on your response.
You may be eligible to participate if 18 years of age or older and have been diagnosed with moderate to severe plaque-type psoriasis for at least 6 months.
PI: Alkousakis, Theodore
  • 720-848-0556
  • psoriasiscolorado@ucdenver.edu
DO YOU LIKE TO EAT? HEALTHY MEN needed to participate in a research study 14-2411
Research whether age affects how fat tissue responds to 1 week of overfeeding
Men who are age 25-40 yr or 55-75 yr overweight or mildly obese sedentary to moderately active non-smokers
PI: Van Pelt, Rachael
  • 720.848.6418
  • Tracy.swibas@ucdenver.edu
Exercise for Healthy Aging 14-2207
To determine whether a high versus a moderate intensity of cardiovascular + strength training has a greater improvement on health and quality of life.
Eligibility: Men aged 50-68, no major health problems that would interfere with the ability to exercise; if diabetic, must be well-controlled on oral medications (no insulin); body mass index between 20 and 40; no current/chronic infections.
PI: Erlandson, MD, Kristine
  • 303-724-4941
  • kristine.erlandson@ucdenver.edu
Give Us a Hand 12-1084
To better understand Multiple Sclerosis in children and teens.
Between the ages of 3-20 AND have Multiple Sclerosis diagnosed before 18 OR Do not have MS
PI: Schreiner, Teri
  • 303-724-3635
  • kathryn.connelly@ucdenver.edu
Are you an African American with asthma? HS-2805
 We are studying why some African American people have trouble with their asthma despite taking asthma medications.
 Children age 5-17 and non-smoking Adults age18 and older who have asthma symptoms despite asthma treatment • African American ancestry (have at least one    African American grandparent)
PI: Wechsler, MD, Michael
  • 303-398-1443
  • sundstromd@njhealth.org
Peanut and Tree-Nut Allergy Research Study 13-2102
The purpose of this study is to determine how the body's immune system interacts with nuts and other foods to cause allergic reaction.
6-75 years of age. Have a diagnosis of peanut and/or tree-nut allergy made by either skin test or blood tests. Have no known peanut and/or tree-nut allergy.
PI: Dreskin, Stephen
  • 303-724-7193
  • Spodra.Eglite@ucdenver.edu
Do you have human growth hormone (hGH) deficiency? 13-2629
Primary: To demonstrate a clinical superiority of MOD-4023 over placebo in terms of decrease in Fat Mass (FM) in adult subjects with Growth Hormone Deficiency Secondary a. To determine the efficacy of MOD-4023 over placebo in other body composition variables (such as lean body mass and waist-to-hip ratio) b. To evaluate the safety and tolerability of MOD-4023 over placebo in adult subjects with GHD c. To determine the IGF-I and IGFBP-3 serum levels
Adult men and women aged 23 to 70 years of age diagnosed with either adult or childhood onset growth hormone deficiency (GHD).
PI: Wierman, Margaret
  • 720-848-7710
  • Shannon.Moore@ucdenver.edu
Are you a parent of a child with a developmental disability and willing to contribute to a research project to increase awareness and understanding? 14-1287
The purpose of this study is to gain knowledge on the topic of everyday stressors that affect the lives of children with developmental disabilities, as well as their parents/caregivers
Are you a parent of a child with a developmental disability and willing to contribute to a research project to increase awareness and understanding?
PI: Benson, Brenna
  • (303) 520-7346
  • brenna.benson@ucdenver.edu
Healthy Female Adults Needed!!! 07-0816
For brain imaging research study on how the brain works with we taste sweets. Your participation could help us to develop treatments and preventive measures for anorexia nervosa and obesity
Healthy females 22 to 29 who are right-handed, free of medication with no serious medical conditions, permanent metal implants or braces/retainers, and are at a healthy body weight.
PI: Frank, Guido
  • 720-777-4026
  • imaging.research@childrenscolorado.org
Do you have an egg allergy? HS-2764
To see if taking Baked Egg Therapy vs. Oral Immunotherapy may help egg-allergic children tolerate eggs.
males and females 3 to 16 years old, with documented egg allergy, ability to make regular visits to National Jewish Health for up to 2 years.
PI: Leung, Donald
  • 303-398-1618
  • ReamesR@NJHealth.org
Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) 15-0023
Pitavastatin is a statin that along with diet is used for the treatment of high cholesterol. It also lowers triglyceride levels in the blood. The main purpose of this clinical trial is to see if pitavastatin can prevent heart disease and heart disease related deaths in people with HIV infection who are taking HIV medications.
This study lasts about 6 years (21 visits) and you may be eligible if: • You have HIV and are between the ages of 40 and 75. • You have been on antiretroviral therapy (ART) for at least 6 months. • You have a CD4+ cell count > 100. • You have no history of cardiovascular disease (history of heart attack or stroke, etc.). • You are not currently using a statin drug.
PI: Campbell, MD, Thomas
  • 303-724-0712
  • graham.ray@ucdenver.edu
We are looking for Healthy Men and Women to participate in a research study to determine how Exercise Impacts Fat Metabolism During Sleep 13-0359
The University of Colorado Anschutz Medical Campus is recruiting healthy men and women to participate in a research study investigating how exercise performed during the day impacts hormones and metabolism during sleep.  Adults spend about one-third of their lives sleeping yet little is known about metabolism during this period or how day time exercise influences sleeping metabolism.  Learning more about sleeping metabolism will improve our understanding of how the body regulates body weight.
This research study is looking for healthy men and women aged 20 to 35 years, who have a BMI < 30, exercise less than 3 days per week, and have a regular sleep schedule.
PI: Rynders, Corey
  • 720-848-6461
  • corey.rynders@ucdenver.edu
Are you Interested in Being in a Weight Loss Research Study? 13-1550
Volunteers needed for a research study to determine the best time to begin exercise within a lifestyle weight loss program.
• Be a man or woman between 18 and 55 years old • Be generally healthy without diabetes or heart disease • Be a non-smoker • Not currently exercising regularly • Have a BMI between 28 and 40 kg/m2 In order to enroll all participants must meet specific criteria. The criteria listed above is only a partial list of all the requirements to participate in this research study. Only a clinical research staff member can determine eligibility.
PI: Catenacci, Victoria
  • 303-724-9098
  • kristen.bing@ucdenver.edu
Paid Volunteers Needed for high blood pressure study PR2015-149
Looking for participants in clinical studies. Tests conducted to evaluate Blood Pressure devices per FDA requirements.
Subjects must be 3 years of age and have an arm circumference between 12-55cm.  Looking for healthy Adults, and Kids, non-medicated High Blood Pressure, and individuals with large arms/biceps.  Studies conducted year round on an on-going basis. Payment made on a per study basis, typical $50-100/study.
 
PI: Ransom, David
  • 303-884-2499
  • AFedorRN@clinimark.com
Investigations in Gestational Origins of Lifetime Development: Understanding health begins before birth. Are you in your first trimester of Pregnancy? 07-0535
To learn more about how your metabolism is connected to your baby's growth and development
  • Healthy Women ages 18-35 who are 10-14 weeks pregnant with single baby.  With a  BMI of 30-38 who are willing to complete 5 visits during pregnancy and agreeable to an infant blood draw at birth and DXA postpartum.  
There is an option to take part in a 1 year follow-up which entails an additional 4 visits and another DXA at 1 year of life.
PI: Barbour, Linda
  • 303-724-3974
  • catherine.chartier-logan@ucdenver.edu
We are Currently Enrolling People with Down syndrome for a study in Dr. Pelak's Brain and Vision Research lab at the University of Colorado Anschutz Medical Campus. 05-1131
To examine visual brain function in people with mild memory impairments to detect early signs of Alzheimer's Disease.​
Persons 19-30 who have Down Syndrome
PI: Pelak, Victoria
  • 303-724-2184
  • Jerri.Lusk@ucdenver.edu
EMERALD STUDY: Effects of MEtformin on CardiovasculaR function in AdoLescents with Type 1 Diabetes 12-1528
​To determine the effects of Metformin on Cardiovascular Function in Adolescents with Type 1 Diabetes.
  • Persons 12-21 who have Type 1 Diabetes
  • Non-smoker, able to ride a stationary bike
  • You must be willing to take metformin or placebo (sugar pill) for 3 months.
  • Other exclusions apply, please contract study for more information
PI: Nadeau, Kristen
  • 720-777-5774 or 720-777-6143
  • susan.gross@childrenscolorado.oramy.baumgartner@childrenscolorado.org
Children's Hospital, department of Pediatric Neurology is conducting a research study 13-0032
Evaluating the effects of a single treatment of injected BOTOX® (Botulinum Toxin Type A) for chronic migraine(s) in adolescents.
  • Adolescents 12-17 who have no serious medical conditions but have at least 15 headaches a month for the last 6 months. 
  • You not have any previous BOTX treatments or are not currently using any prophylactic medicine.
PI: Kedia, Sita
  • 720-777-8588
  • headacheresearch@childrenscolorado.org
Non-Alcoholic Fatty Liver Disease and Obstructive Sleep Apnea: Mechanistic Links between Hypoxemia and Liver Injury 09-0169
To learn if obstructive sleep apnea and low oxygen levels have a role in developing Non-Alcoholic Fatty Liver Disease (NAFLD).​​​
Children 10-17 who have a normal weight and no serious medical problems
PI: Sundaram, Shikha
  • 720-777-3819
  • Kristen.robbins@childrenscolorado.org
Exercise and Cancer Prevention Research Study 13-2314
The goal of this study is to better understand the biological mechanisms associated with exercise and reduced risk for breast cancer.
  • You must be a female between the ages of 30-45 to participate in this study. 
  • You must be planning to live in the Denver metropolitan area for the next 10 consecutive months. 
  • You should not be a regular exerciser because this study is for people who do not exercise right now; however, you should be willing to participate in an exercise program 4 times per week for 16-weeks.
PI: Bryan, Angela
  • 303-492-9549
  • cuchange@colorado.edu
Are you interested in a supervised exercise intervention? 13-3252
Volunteers are needed for a research study to examine the effects of exercise on food intake and appetite regulation.
  • 21-45 years old
  • Non- smoker
  • Non- Diabetic
  • Exercise no more than 1 time a week
  • Maintained your current weight for last 6 months
  • Have a body mass index (BMI) of 27-35 (check it out at http://nhlbisupport.com/bmi/)
PI: Cornier, Marc
  • 303-724-9024
  • allison.hild@ucdenver.edu
Study of Mood Disorder in Preschool Children 07-0932
We are doing a research study to better understand what mood disorders look like in preschool children.
We are looking for volunteers who:  
  • Are parents of children between the ages of 4 and 6 years 0 months.
  • Are in one of three groups:
    1. Their child has no major mental health problems, and there is no family history of major mood or psychotic disorders.
    2. Their child has been diagnosed with a mood disorder, bipolar disorder, or mood dysregulation disorder. 
    3. Their child has been diagnosed with attention deficit hyperactivity  disorder (ADHD).  
  • Parents or guardians will be asked to:
    • Read and sign a consent form
    • Participate in interviews about their children
  • The  children will be asked to:
    • Participate in a story game
    • Take tests of verbal and nonverbal abilities
How much time will this take?
The visit for the child will last from 1 to 2 hours.  The visit for the parents will last 3 to 5 hours.
PI: Ross, Randy
  • 303-724-6200
  • Kate.Noonan@ucdenver.edu
MRI and Questionnaire Research Study for Patients with MS Taking Tysabri and Healthy Controls 13-2927
This research study plans to learn more about the differences in brain scans and self-reported quality of life between MS patients taking natalizumab (Tysabri) and individuals without MS.
A relapsing Multiple Sclerosis patient 18-55 years old who has been taking Tysabri (natalizumab) for at least 2 years

OR

A healthy individual 18-55 years old without Multiple Sclerosis or other neurological conditions
PI: Miravalle, Augusto
  • 303-724-8388
  • Eric.Engebretson@ucdenver.edu
Understanding how Tysabri and Gilenya Influence the Quality of your Daily Life with Multiple Sclerosis 13-2767
The purpose of this research study is to compare two medications, Tysabri and Gilenya, used in the treatment of multiple sclerosis (MS), through a few self-reported patient surveys. We will ask you to complete online surveys about overall health-related quality of life, disability, fatigue, cognition and productivity. We will also want to review your medical records to understand your MS history with your permission. This study will help us understand how these drugs are impacting each aspect of your daily lives.
  • Between ages 16 and 65
  • Scheduled to start natalizumab or fingolimod for the first time to treat your MS
PI: Nair, Kavita
  • 303-724-8388
  • Eric.Engebretson@ucdenver.edu
Living with MS? 12-1522
To evaluate the safety of a new investigational drug that may help reduce relapses.
  • Between the ages of 18 to 65
  • Participants must have relapsing-remitting multiple sclerosis (RRMS)
PI: Corboy, John
  • 303-724-7421
  • Kristina.Bliss@ucdenver.edu
High Altitude Research Study 14-1514
Subjects needed for a study on how high altitude affects cognitive performance
Male and Female subjects needed that are:
  • Between the ages of 18-45 years old and exercise regularly
  • Healthy: non-smokers and not on medications
  • Willing to stay below 7,000 ft for 3 weeks prior to altitude chamber day
PI: Roach, Robert
  • 303-724-1674
  • altituderesearch@ucdenver.edu
Are you Pregnant or a Nursing Mother? Consider being a part f a Breast Cancer Research. 12-0769
This study will examine changes that occur in the breast tissue, blood and urine of a woman after she has given birth to a child. The study will examine how a woman’s breast and her cells change after pregnancy and breast feeding and how her immune system interacts with these changes. The immune system is a complex network of cells that identify our tissues as “self” or “foreign” as well as normal cells or cancer cells. We hope to discover how a woman’s breast changes after pregnancy or breast feeding to see if this time point in a woman’s life could be targeted to prevent breast cancer.
You are being asked to be in this research study because you are pregnant or were recently pregnant and have not had breast cancer or another autoimmune disease.
PI: Borges, Virginia
  • 303-724-6077
  • emily.rozzo@ucdenver.edu
Do You have type 1 diabetes? 14-2423
To learn more about an investigation study drug
    • Persons 18 to 30 years who have had Type 1 Diabetes for 12 months
    • Have a stable insulin treatment (MDI or pump) 3 months and an A1C 9.0
    • Not using an antidiabetic agent other than insulin or insulin analogue
    • Willing to take study drug or placebo pills daily for 3 months
    • Not pregnant, breast-feeding or intending to become pregnant
    • Other inclusion/exclusions apply, please contact study coordinator for more information
 
PI: Paul R, Wadwa
  • 303-724-9267
  • cierra.sullivan@ucdenver.edu
Will You Be a Caregiver For Your Loved One During Transplant? 13-2639
We are conducting a research study to assess treatments to reduce the effects of stress on caregivers of patients experiencing an allogeneic transplant.
Patient inclusion criteria include: 1) receiving an allogeneic HSCT, 2) able to read and speak English, 3) telephone access. Caregiver inclusion criteria include: 1) the person in the patient's life who is primarily responsible for care decisions, emotionally invested in the patient's care, provides instrumental care such as transportation, and available if randomized to the fPER group to participate in the majority of intervention sessions, 2) able to read and speak English, 3) willingness to use a Smartphone, 4) absence of a serious medical condition likely to influence hair cortisol, 5) no steroid medications, and 6) over the age of 18 years.
PI: Laudenslager, Mark
  • 303-724-9279
  • Carewell@ucdenver.edu
DO YOU HAVE GESTATIONAL DIABETES? Would you like help with your GDM Diet? 14-1358
Research Subjects Needed to Participate in a Diet Research Study in Women with Gestational Diabetes
Who can qualify? * Highly motivated pregnant women with Gestational Diabetes not taking medicine for blood sugar control * Women willing to follow 1 of 2 healthy diets for blood sugar control * Women willing to complete 6 visits during pregnancy with infant follow up * Gestational age: <31 weeks; singleton pregnancy * Healthy  women, age : 20-36 years * No high blood pressure * Overweight or Obese
PI: Hernandez, Teri
  • 303-724-3974
  • catherine.chartier-logan@ucdenver.edu
Volunteers needed for a NASH therapeutic trial 14-2108
Clinical research study of an investigational product for the treatment of non-alcoholic steatohepatitis (NASH)
*≥18 years old *Confirmed diagnosis of NASH *No other liver disease *No excessive alcohol use (no more than 2 drinks/day for women and 3 drinks/day for men)
PI: Bambha, Kiran
  • 303-724-1871
  • colin.jenks@ucdenver.edu
We are looking for Healthy Men and Women to participate in the WATCH CALORIE Research Study 15-1570
The study will examine how diet impacts circadian clocks in abdominal fat tissue
Healthy women aged 20 to 35 years A BMI between 25- 30 Exercise less than 4 days per week Have a regular sleep schedule
PI: Rynders, Corey
  • (720) 848-6461
  • corey.rynders@ucdenver.edu
Type 2 Diabetes and Exercise Research Study 11-0909
Perceived exertion during exercise
Person 50-70 with or without Type 2 diabetes who exercise vigorously less than one hour per week and have normal blood pressure.  You should have a BMI between 25-35 and have not smoked for a least one year.
PI: Huebschmann, Amy
  • 303-724-2255
  • Ian.Leavitt@ucdenver.edu
Participants Ages 12-15 years old Needed for Research Study 04-0311
To learn about how children with absence epilepsy compare to healthy children in areas such as behavior, neuropsychological skills and quality of life.
Healthy hispanic individuals who are 12-15 years; No history of seizures, seizure like episodes, neurological diseases or a loss of consciousness greater than 5 minutes in their immediate family
PI: Levisohn, Paul
  • 720-777-8608
  • Nanastasia.Welnick@childrenscolorado.org
Participants Needed for an Exercise Study for People with Multiple Sclerosis 14-0295
Researchers from the Neurophysiology of Movement Laboratory on the University of Colorado Boulder campus and the Multiple Sclerosis Center on the University of Colorado Anschutz Medical Campus are conducting a study to investigate the capacity of neuromuscular electrical stimulation to improve walking in persons with multiple sclerosis.
-Between 18 to 55 years of age -Have clinically confirmed diagnosis of MS -Are able to talk but have some difficulty walking
PI: Enoka, Roger
  • 303-724-4644
  • Roger.Enoka@colorado.edu
Healthy Adolescents Needed 07-0709
Psychological study on how flexible your brain can shift from one task to another.
-Female -age 12-17 years old -in good health -on no medication
PI: Frank, Guido
  • 720-777-4026
  • imaging.research@childrenscolorado.org
Help test a mobile app for postpartum moms 14-1173
This research study will test a mobile application to learn more about how to best deliver information about diet and physical activity for postpartum women at elevated risk for diabetes and heart disease.
You may qualify for this study if you:  Are between 18-45 years old  Are in your third trimester of pregnancy or have given birth in the last 24 weeks  Have a postpartum BMI: 25-45 kg/m2  Have access to and be willing to use a wi-fi enabled iPhone or an iPod  Have a history of one or more of the following complications in your most recent pregnancy: o Gestational diabetes mellitus o Preeclampsia o Gestational hypertension o Pre-term delivery (32-37) weeks o Small for gestational age (
PI: Nicklas , Jacinda
  • 303-724-8898
  • jessica.jaramillo@ucdenver.edu
ATTENTION: A CLINICAL RESEARCH STUDY FOR WOMEN. Are you interested in participating in a clinical trial studying an investigational vaginal ring for birth control? 15-0332
Study to evaluate whether the investigational vaginal ring is safe and effective.
The study staff will determine if you’re eligible to participate. At a minimum, you must meet the following criteria: • Are a woman 18 years of age or older • Are heterosexually active and at risk for pregnancy • Must agree to avoid other forms of birth control while participating in the study
PI: Teal, Stephanie
  • 303.724.5284
  • Cricket.mchugh@ucdenver.edu
Healthy Individuals needed for Genetic Study of Granulomatous Interstitial Lung Disease. HS-2765
To investigate genetic factors associated with the disease sarcoidosis.
Must be 18 years or older with no history of chronic lung disease (including asthma) or connective tissue/rheumatological disease. Participants must complete a questionnaire and have a small blood draw.
PI: Maier, Lisa
  • 303-270-2867
  • schrocks@njhealth.org
We are seeking physically active women and men for a research study on PTH and Calcium Responses to Exercise (PACE) in Older Adults 15-0250
To determine 1) if sweating rate during exercise affects the decrease in blood calcium level, and 2) if this causes an increase in a hormone called parathyroid hormone or PTH that causes bone to release calcium.
 A 60-80-year-old woman or man in generally good health  Often walk for exercise and can walk for an hour at a time  Not taking osteoporosis medication  No history of Diabetes or Cardiovascular Disease
PI: Wherry, Sarah
  • 7208486376
  • toby.wellington@ucdenver.edu
Are you interested in trying inhaled insulin for your meal/correction doses? 15-1112
The purpose of this study is to evaluate the blood levels of the study medication (Afrezza®), for blood sugar levels and safety after 4 weeks of treatment in children and adolescents between 4-17 years of age with T1DM
Age 4-17 years Type 1 Diabetes for at least 1 year A1C between 7-10% Stable Insulin doses for the past 6 weeks
PI: Wadwa, R. Paul
  • 303-724-8095
  • bao-khanh.tran@ucdenver.edu
Social Networks of Abused Prescription Pills in Youth (SNAPPY) Research Study 15-0504
The purpose of this research study is to learn more about the misuse of prescription pills and the risk for injection drug use.
You may be selected to participate in the study if you are: • Between the ages of 15 and 24 • Willing to provide information about people in your life and things you do with them • Currently using prescription opioids without a doctor’s prescription or in ways other than what was prescribed OR • Currently using heroin after a period of misusing prescription opioids
PI: Al-Tayyib, Alia
  • 1-888-897-3224
  • Alia.AlTayyib@dhha.org
We are seeking physically active men for a research study on PTH and Calcium Responses to Exercise (PACE) 12-0767
This study will determine how much calcium enters and leaves the blood during exercise.  The results of this study will help us find out why some adults who exercise a lot sometimes have low bone density
• Men in generally good health, aged 18-45 years • Regularly cycle for exercise and can ride for an hour at a vigorous intensity • Not taking medication for osteoporosis • No history of asthma
PI: Kohrt, Wendy
  • 7208486376
  • toby.wellington@ucdenver.edu
We are looking for adolescents who have received a solid organ transplant for a telehealth group research study! 13-2997
Learning how to improve adherence in adolescents who have received solid organ transplants and determining whether telehealth can be used to facilitate groups for teenage transplant recipients.
Teens between the ages of 13 and 17 who have received a heart, liver, or kidney transplant.
PI: Buchanan, Cindy
  • 720-777-5529
  • cindy.buchanan@childrenscolorado.org
Women with Obesity Needed! 07-0816
For brain imaging research study on how the brain works with we taste sweets. Your participation could help us to develop treatments and preventive measures for anorexia nervosa and obesity
Females 18 to 25 years old who are right-handed, currently overweight, have a body mass index (BMI) over 30, and no permanent implants or braces
PI: Frank, Guido
  • 720-777-4026
  • imaging.research@childrenscolorado.org
A Study to Evaluate Dolutegravir plus Lamivudine Dual Therapy for the Treatment of Naive HIV-1-Infected Participants 15-1624
The main purpose of this study is to evaluate how well a two-drug combination of study drugs (dolutegravir plus lamivudine) will suppress HIV at 24 weeks after starting treatment. The study will also look at the safety and tolerability of this study drug combination, and factors that may affect how well it works in different individuals.
-HIV-1 infected men and women at least 18 years of age -Have not taken HIV medications (except for successful prevention of HIV infection) -No evidence of resistance to the type of anti-HIV drugs being used in the study -Have blood HIV level (viral load) of at least 1000 copies/mL but less than 500,000 copies/mL -No active Hepatitis B infection
PI: Campbell, MD, Thomas
  • 303-724-0712
  • graham.ray@ucdenver.edu
Neutralize HIV 15-0499
To see if VRC01 is safe and well tolerated in HIV positive. To see if VRC01 helps reduce the number of HIV infected cells in the body.
-HIV infected persons between 18 and 60 years of age -On HIV treatment for at least 2 years and no changes in the drug regimen for the past 90 days -CD4 count greater than 200 -Undetectable HIV viral load for the past 2 years -No chronic Hepatitis B or Hepatitis C
PI: Campbell, MD, Thomas
  • 303-724-0712
  • graham.ray@ucdenver.edu
Participants needed for a Balance and Fall-Risk Research Study for People with Multiple Sclerosis 15-1806
This study involves balance and head movement testing aimed at predicting risk of falls
Are between the ages of 30 and 60 years
• have MS
• are able to turn your head at least 30 degrees to the left,
• have not experienced a fall in the last 3 months
PI: Hebert, Jeffrey
  • 303-724-4717
  • molly.strobel@ucdenver.edu
Volunteers Needed for a Research Study about Rheumatoid Arthritis 14-1751
The purpose of this study is to learn more about how rheumatoid arthritis develops in women by studying women who do not have rheumatoid arthritis. Your participation in this study will help us determine if certain hormone or environmental factors affect the chances of developing protein markers associated with rheumatoid arthritis.
• You are a woman at least 18 years old • You do NOT have rheumatoid arthritis (RA)
PI: Demoruelle, Kristen
  • (303) 724-8319 or (303) 724-8330
  • Courtney.2.Anderson@ucdenver.edu
Do you like food? 13-1786
Participants needed for a study on foods Participants in this study will: - Rate a series of food pictures - Watch pictures of food during fMRI recording, to measure brain responses to the pictures - Complete an fMRI task with images shown briefly before food pictures. - May also eat a buffet-style breakfast and lunch. - Be compensated for their time (between 2-6 hours)
- Adults between 18-65 years old - BMI > 25
PI: Legget, PhD, Kristina
  • 303-724-9024
  • allison.hild@ucdenver.edu
Healthy Women Needed 15-0474
To understand how weight affects reproductive health and fertility potential
In order to be eligible you must: Be a healthy women age 21-39 with BMI between 18.5 and 24.9 or greater than 30 Have regular menstrual cycles (25-40 days) Not currently using hormones (like birth control medication) Be willing to have frequent blood samples drawn In order to enroll all participants must meet specific criteria. The criteria listed above is only a partial list of all the requirements. Only a clinical research staff member can determine eligibility.
PI: Polotsky, MD MS, Alex
  • 303-724-9643
  • michelle.sheehy@ucdenver.edu
JUST DIAGNOSED WITH SHINGLES? 13-2122
This study will look at the body's immune response (how the body fights infection) to the onset of shingles. 1-2 study visits for blood draws, over the course of 3 months.
18+ years of age; NO PRIOR HISTORY of shingles; have NEVER received the shingles vaccine; have DEVELOPED SHINGLES within the last 10 days.
PI: Levin, Myron
  • 303/724-2454
  • nancy.lang@ucdenver.edu
protein and infant growth: Do you have a child younger than 6 months 14-0139
Participants in this research study on protein from complementary foods (meat or dairy) and infant growth, will learn how protein consumption affects your child’s growth, fat gain, and gut health from 6 to 12 months of age.  
To qualify, you child needs to be: 1. Formula fed, or not on breast-milk longer than 1 month. 2. Younger than 6 months. 3. Generally healthy. You will receive commercially available complementary foods for 7 months, Receive infant formula at no cost for 7 months, You will know your child's body fat and fat free mass and blood lipid level.
PI: Krebs, Nancy
  • 303-724-3248
  • minghua.tang@ucdenver.edu
Volunteers Needed: Thinking and Memory in Parkinson's Disease 13-2724
This research study aims to better understand how changes in brain activity may be related to thinking problems in Parkinson's Disease and to determine whether, by stimulating certain areas, thinking and memory can be improved.
Person's with Parkinson's Disease with mild thinking and memory problems. Between 40-90 years old. No metal in your body. No implant. Not taking any medication to improve memory. Not taking stimulants or seizure medication.
PI: Kluger, Benzi
  • 303-724-8885
  • Christine.Martin@ucdenver.edu
HAVE YOU OR YOUR CHILD BEEN DIAGNOSED WITH ASTHMA? HS-2827
We are looking for volunteers to participate in an N.I.H. funded research study.
Children 12 years of age and older and non-smoking Adults who have mild to moderate asthma who are not currently taking inhaled steroid medication
PI: Martin, Richard
  • 303-398-1443
  • stevensa@njhealth.org
Do You or Someone You Know Suffer From Relapse Remitting Multiple Sclerosis (RRMS)? 13-2209
The University of Colorado Denver is conducting a clinical trial to evaluate the effectiveness, safety and tolerability of two doses of oral administration of laquinimod in subjects with Relapse Remitting Multiple Sclerosis (RRMS). Patients that suffer from RRMS may experience a gradual increase of their disability over time. The purpose of this study is to find out whether laquinimod is safe and effective in slowing the rate of disability progression.
-Between the ages of 18 and 55 -Have clinically confirmed diagnosis of Multiple Sclerosis (MS) with relapse onset disease or relapsing-remitting disease course -Have had at least one documented relapse within 12 months prior to starting this study -Have not been treated with Natalizumab (Tysabri) or Rituximab 2 years prior to starting this study
PI: Vollmer, Timothy
  • 303-724-6351
  • Nicola.Haakonsen@ucdenver.edu
Sedentary Behavior Research Study 14-0429
This research study plans to learn more about how the time we spend seated affects your health
Healthy male and female Age: 19-45 With BMI: 27-33 you may check this at: http://nhlbisupport.com/bmi/ Be seated more than 6hr/d Be physically active on less than 3-4 days/wk
PI: Bergouignan, Audrey
  • 303-724-9026
  • nathan.dejong@ucdenver.edu
Healthy Minority Volunteers Needed 13-0427
This study plans to learn more about how tenofovir and emtricitabine (Truvada) build up in cells in blood and hair. Participation will include two 12 week dosing periods separated by a 12 week washout period (total duration is 36 weeks). Eligible participants will be given the supply of medications for the study.
Documented negative testing for HIV and hepatitis B Not at risk for HIV Study population balanced by Caucasian, African-American, Hispanic race. African American and Hispanic participants are currently needed. Age 18-50 years Able to meet study personnel on Anschutz Medical Campus for directly observed dosing with study medication, or by audio-visual communication with a mobile cellular device when off Campus
PI: Anderson, Peter
  • 303-724-8296
  • Kayla.bushman@ucdenver.edu
University of Colorado Recruiting Patients for a Clinical Research Study for Psoriasis 13-2727
The research study compares the effect of treatments, such as Humira and phototherapy, on inflammation in the body and cardiovascular disease. This study will look for systemic vascular inflammation in subjects enrolled in this study, with a test called FDG-PET/CT (Fluorodeoxyglucose-positron emission tomography computed tomography).
We are looking for males and females 18 years of age and older with a diagnosis of psoriasis for at least 6 months
PI: Alkousakis, Theodore
  • 720-848-0556
  • aleksandra.florek@ucdenver.edu
Participate in a research study about body image dissatisfaction and psychosocial distress among breast cancer patients 15-0004
The purpose of this research study is to 1) determine the feasibility and impact of a 2 day body image workshop on breast cancer patients’ body image dissatisfaction, depression, and quality of life and 2) understand the relationships between body image, quality of life, and depression among patients with breast cancer.
Participants must be: 1) between the ages of 18-65, 2) histological or cytological confirmation of breast cancer (any clinical stage is allowed); 3) within 6 months of completion of surgery or final chemotherapy/radiation treatment for breast cancer, 4) experiencing concerns specific to body image.
PI: Pearson-Mauro , Adria
  • 720-251-4803
  • cubodyimage@gmail.com
Exercise for Healthy Aging in HIV 14-2207
Determine the best “dose” of exercise in people aging with HIV, and whether or not the dose differs from people without HIV.
Men and women aged 50-70, on antiretroviral therapy for a minimum of 2 years with no detectable viral load, CD4 count >200; no active hepatitis C or hepatitis B; no major health problems that would interfere with the ability to exercise; if diabetic, must be well-controlled on oral medications (no insulin); body mass index between 20 and 40; no current/chronic infections besides HIV.
PI: Erlandson, MD, Kristine
  • 303-724-4941
  • kristine.erlandson@ucdenver.edu
Would you like to follow your baby's brain development? Study of Pre and Postnatal Infant Brain Growth and Development 15-0707
will examine brain development during and after pregnancy, investigating different aspects of mother and infant nutritional health on your infant’s brain growth and cognitive development.  
As an expectant mother you can participate if you are less than 22 weeks pregnant; or if your healthy newborn infant is between 3 and 15 months of age.
PI: Deoni, Sean
  • (720)777-8036
  • info@childimaginglab.org
We are looking for women who have not been diagnosed with cancer to participate in a research study. 11-0357
A comparison of immune function from unaffected individuals for the study of tumor-induced immune suppression
To participate you must: - Older than 18 - Be willing to make a one-time blood donation - Not be diagnosed with an immune disease such as diabetes or rheumatoid arthritis You could make a difference in the future of women!
PI: Borges, Virginia
  • 303-724-6077
  • emily.rozzo@ucdenver.edu
If you child suffers from rashes or skin allergies he or she may qualify to take part in a research study. 12-1208
To test seven new antigens on the child and adolescent population to add to the current standard test
Children and adolescents 6-17 diagnosed with contact dermatitis or may have contact dermatitis who are willing to wear test patches for 2 days and are available for follow-up visits
PI: Dunnick, Cory
  • 303-724-9155
  • Teresa.Derian@ucdenver.edu
MS Volunteers Needed for Research Study 12-1388
Looking to see if there is a cognitive improvement with the treatment of oral estriol as compared to oral placebo
We are looking for: • Women 18-50 years old • Diagnosed with definite relapsing-remitting, secondary-progressive multiple sclerosis or primary-progressive multiple sclerosis • MS disease duration of 15 years or less • On stable dose of standard MS treatment with Copaxone®, Betaseron® (or Extavia®), Rebif®,Avonex®, Gilenya®, Aubagio®, Tecfidera®, or no treatment ----You are not eligible for the study if you are pregnant, breast-feeding, smoke, or have other serious medical conditions.
PI: Corboy, John
  • 303-724-6351
  • Nicola.Haakonsen@ucdenver.edu
  
  
Protocol Title
08-0450Abzug, Mark
IMPAACT P1063, PHASE I/II SAFETY AND EFFICACY INVESTIGATION OF ATORVASTATIN FOR TREATMENT OF INCREASED LDL CHOLESTEROL IN HIV-INFECTED CHILDREN, ADOLESCENTS, AND YOUNG ADULTS, VERSION 2.0
03-993Ahnen, Dennis
COLORECTAL CHEMOPREVENTION WITH CALCIUM AND VITAMIN D (THE VITAMIN D/CALCIUM POLYP PREVENTION STUDY)
02-805Anderson, Clark
RANDOMIZED EVALUATION OF RECURRENT STROKE COMPARING PFO CLOSURE TO ESTABLISHED CURRENT STANDARD OF CARE TREATMENT - RESPECT TRIAL
09-0945Badesch, David
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multi-center trial of Monoclonal Antibody To Cd20 (Rutiximab) For The Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (Ssc-Pah)
07-0124Beresford, Thomas
A DOUBLE-BLIND, CONTROLLED STUDY OF ARIPIPRAZOLE IN CO-MORBID SCHIZOPHRENIA AND COCAINE DEPENDENCE
08-0582Beresford, Thomas
A Double-Blind Trial of Divalproex Sodium for Affective Lability and Alcohol use Following Traumatic Brain Injury
10-0875Brenner, Lisa
A pilot phase II study of hyperbaric oxygen for persistent post-concussive symptoms after mild traumatic brain injury (HOPPS)
05-1106Chan, Laurence
BELATCEPT EVALUATION OF NEPHROPROTECTION AND EFFICACY AS FIRST-LINE IMMUNOSUPPRESSION TRIAL (BENEFIT) #IM103008
10-1066Chonchol, Michel
SYSTOLIC BLOOD PRESSURE INTERVENTION TRIAL (SPRINT)
08-0721Cohen, Mindy
THE USE OF INTRAOPERATIVE INTRATHECAL MORPHINE VERSUS EPIDURAL EXTENDED RELEASE MORPHINE FOR POSTOPERATIVE PAIN CONTROL IN PEDIATRIC PATIENTS UNDERGOING POSTERIOR SPINAL FUSION
02-498Dabelea, Dana
DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)
09-0822Douglas, Ivor
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF DEXMEDETOMIDINE (PRECEDEX®), WITH LORAZEPAM RESCUE, FOR THE MANAGEMENT OF SEVERE ALCOHOL WITHDRAWAL SYNDROME (AWS) AND ALCOHOL WITHDRAWAL DELIRIUM (AWD)
03-1250Eckhardt, Sue
A CONTINUATION PROTOCOL FOR PI-88 IN PATIENTS WITH ADVANCED MALIGNANCIES
10-0853Edelstein, Charles
MULTI-CENTER, OPEN-LABEL, EXTENSION STUDY TO EVALUATE THE LONG-TERM EFFICACY AND SAFETY OF ORAL TOLVAPTAN TABLET REGIMENS IN SUBJECTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (Adpkd). 156-08-271
00-954Elias, Anthony
SWOG N9831 PHASE III TRIAL OF DOXORUBICIN AND CYCLOPHOSPHAMIDE (AC) FOLLOWED BY WEEKLY PACLITAXEL WITH OR WITHOUT TRASTUZUMAB AS ADJUVANT TREATMENT FOR WOMEN WITH HER-2 OVEREXPRESSING NODE POSITIVE OR HIGH-RISK NODE NEGATIVE BREAST CANCER
03-1030Elias, Anthony
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE III STUDY COMPARING GW572016 AND LETROZOLE VERSUS LETROZOLE IN SUBJECTS WITH ESTROGEN/PROGESTERONE RECEPTOR-POSITIVE ADVANCED OR METASTATIC BREAST CANCER (EGF 30008).
05-1078Elias, Anthony
SWOG 0307 PHASE III TRIAL OF BISPHOSPHONATES AS ADJUVANT THERAPY FOR PRIMARY BREAST CANCER
07-0325Elias, Anthony
S0622 PHASE II STUDIES OF TWO DIFFERENT SCHEDULES OF DASATINIB (NSC-732517) IN BONE-METASTASIS PREDOMINANT METASTATIC BREAST CANCER.
08-0192Elias, Anthony
ALTTO: ADJUVANT LAPATINIB AND/OR TRASTUZUMAB TREATMENT OPTIMIZATION STUDY. A RANDOMIZED MULTICENTER OPEN LABEL PHASE III STUDY OF ADJUVANT LAPATINIB TRASTUZUMAB THEIR SEQUENCE AND THEIR COMBINATION IN PATIENTS WITH HER2/ERBB2 POSITIVE PRIMARY BREAST CANCER
10-0374Elias, Anthony
I-SPY 2 TRIAL: (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and MoLecular Analysis 2)
10-0379Elias, Anthony
PARP Inhibition after Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer or ER/PR +, HER2 negative with known BRCA1/2 Mutations
01-410Elias, Ellen
CHOLESTEROL AND ANTIOXIDANT TREATMENT IN PATIENTS WITH THE SMITH-LEMLI-OPITZ SYNDROME (SLOS)
10-0894Everson, Greg
NON-INVASIVE ASSESSMENT OF DISEASE PROGRESSION IN PRIMARY SCLEROSING CHOLANGITIS
08-0866Flaig, Thomas
CHAARTED: CHEMOHORMONAL THERAPY VS ANDROGEN ABLATION RANDOMIZED TRIAL FOR EXTENSIVE DISEASE IN PROSTATE CANCER
09-0998Flaig, Thomas
CALGB - 90601: A randomized double-blinded phase III study comparing gemcitabine, cisplatin, and bevacizumab to gemcitabine, cisplatin, and placebo in patients with Advanced transitional cell carcinoma
04-0625Foreman, Nicholas
ACNS0331: A STUDY EVALUATING LIMITED TARGET VOLUME BOOST IRRADIATION AND REDUCED DOSE CRANIOSPINAL RADIOTHERAPY (18.00 GY) AND CHEMOTHERAPY IN CHILDREN WITH NEWLY DIAGNOSED STANDARD RISK MEDULLOBLASTOMA: A PHASE III DOUBLE RANDOMIZED TRIAL
08-0384Frank, Guido
VIRTUAL REALITY: A NEW TOOL TO TREAT EATING DISORDERS
07-0223Furuta, Glenn
EOSINOPHILS AND INTESTINAL INFLAMMATION
01-284Gardner, Edward
A STUDY OF THE EFFECTIVENESS AND TOLERABILITY OF WEEKLY RIFAPENTINE/ISONIAZID FOR THREE MONTHS VERSUS DAILY ISONIAZID FOR NINE MONTHS FOR THE TREATMENT OF LATENT TUBERCULOSIS INFECTION [TBTC STUDY 26]
08-0175Gardner, Edward
CLOFAZIMINE USE IN LONG-TERM TREATMENT OF LEPROSY (PHASE III)
09-0124Gardner, Edward
STRATEGIC TIMING OF ANTIRETROVIRAL TREATMENT (START 001), VERSION 2.0, 25 OCTOBER 2010
03-683Garrington, Timothy
AHOD0031, A PHASE III GROUP-WIDE STUDY OF DOSE-INTENSIVE RESPONSE-BASED CHEMOTHERAPY AND RADIATION THERAPY FOR CHILDREN AND ADOLESCENTS WITH NEWLY DIAGNOSED INTERMEDIATE RISK HODGKIN DISEASE
03-239Giller, Roger
AALL0031 A CHILDREN'S ONCOLOGY GROUP PILOT STUDY FOR THE TREATMENT OF VERY HIGH RISK ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN AND ADOLESCENTS
10-1009Giller, Roger
Defibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study
09-0899Ginde, Adit
VITAMIN D SUPPLEMENTATION AND ACUTE RESPIRATORY INFECTION IN OLDER NURSING HOME RESIDENTS
01-348Glode, Michael
AUTOLOGOUS PAP-LOADED DENDRITIC CELL VACCINE (APC 8015, PROVENGE) IN PATIENTS WITH NON-METASTATIC PROSTATE CANCER WHO EXPERIENCE PSA ELEVATION FOLLOWING RADICAL PROSTATECTOMY IN RANDOMIZED, CONTROLLED, DOUBLE-BLIND TRIAL
08-0199Gonzalez, Rene
PHASE II STUDY OF IMATINIB IN PATIENTS WITH MUCOSAL OR ACRAL/LENTIGINOUS MELANOMA OR MELANOMAS THAT ARISE ON CHRONICALLY SUN DAMAGED SKIN
05-0913Gore, Lia
ADVL04P2, A FEASIBILITY PILOT AND PHASE 2 STUDY OF CHEMOIMMUNOTHERAPY WITH EPRATUZUMAB (IND# 12034) FOR CHILDREN WITH RELAPSED CD22-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
10-0479Gore, Lia
ADVL0912, A Phase ½ Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-MET, in Children with Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma
07-0165Gottlieb, Peter
EFFECT OF ANTITHYMOCYTE GLOBULIN ON PRESERVING BETA-CELL FUNCTION IN NEW ONSET TYPE 1 DIABETES MELLITUS
09-0667Gottlieb, Peter
THE EFFECTS OF OPEN LABEL ALPHA1-ANTITRYPSIN ON THE PROGRESSION OF TYPE 1 DIABETES IN SUBJECTS WITH DETECTABLE C-PEPTIDE
10-1074Gottlieb, Peter
Anti-CD3 MAB (eplizumab) for Prevention of Diabetes in Relatives at-Risk for Type 1 Diabetes Mellitus
01-932Greffe, Brian
ANBL0032 PHASE III RANDOMIZED STUDY OF CHIMERIC ANTIBODY 14.18 (CH 14.18) IN HIGH RISK NEUROBLASTOMA FOLLOWING MYELOABLATIVE THERAPY AND AUTOLOGOUS STEM CELL RESCUE
04-0119Greffe, Brian
AEWS0331, EUROPEAN EWING TUMOR WORKING INITIATIVE OF NATIONAL GROUPS, EWING TUMOR STUDIES 1999 (EURO-E.W.I.N.G. 99)
01-101Guntupalli, Saketh
GOG#184 - A RANDOMIZED PHASE III STUDY OF TUMOR VOLUME DIRECTED PELVIC PLUS OR MINUS PARA-AORTIC IRRADIATION FOLLOWED BY CISPLATIN AND DOXORUBICIN OR CISPLATIN, DOXORUBICIN AND PACLITAXEL FOR ADVANCED ENDOMETRIAL CARCINOMA
07-1235Guntupalli, Saketh
GOG 0213 PHASE III RANDOMIZED CONTROLLED CLINICAL TRIAL OF CARBOPLATIN AND PACLITAXEL (OR GEMCITABINE) ALONE OR IN COMBINATION WITH BEVACIZUMAB (NSC #704865, IND # 113912) FOLLOWED BY BEVACIZUMAB AND SECONDARY CYTOREDUCTIVE SURGERY IN PLATINUM SENSITIVE RECURRENT OVARIAN, PERITONEAL PRIMARY AND FALLOPIAN TUBE CANCER. NCI-SUPPLIED AGENTS: BEVACIZUMAB (NSC #704865, IND #113912)
09-0736Gutman, Jonathan
TRANSPLANTATION OF UMBILICAL CORD BLOOD IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES USING A REDUCED-INTENSITY PREPARATIVE REGIMEN
09-0817Gutman, Jonathan
Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Hematological Malignancies Using a Treosulfan Based Preparative Regimen
10-1308Gutman, Jonathan
A Pilot Study to Evaluate the Co-infusion of Ex Vivo Expanded Umbilical Cord Blood Progenitors with an Unmanipulated Cord Blood Graft in Patients Undergoing Umbilical Cord Blood Transplantation for Hematologic Malignancies; A multi-center trial coordinated by the FHCRC
04-0005Hassell, Kathryn
CLINICAL CORRELATION AND COST ANALYSIS OF SICKLE CELL PATIENTS UNDERGOING CHRONIC ERYTHROCYTAPHERESES.
11-0042Haugen, Bryan
A Phase II Study of GW786034 (Pazopanib) in Advanced Thyroid Cancer
07-1223Heard, Kennon
A PHASE III MULTI-CENTER CLINICAL TRIAL OF ANALATRO [ANTIVENIN LATRODECTUS (BLACK WIDOW) EQUINE IMMUNE F(AB)2] IN PATIENTS WITH SYSTEMIC LATRODECTISM
10-0625Jalal, Diana
Is Uric Acid a Mediator of Endothelial Dysfunction in Patients with Chronic Kidney Disease?
04-0579Jenkins, Herman
MET FULLY IMPLANTABLE OSSICULAR STIMULATOR
07-0084Johnson, David
APPLICATION FOR HUMANITARIAN USE DEVICE/HDE. HDE NUMBER: 980006 THERASPHERE
10-0078Johnson, Richard
STUDY OF COBALT'S ROLE IN EXCESSIVE ERYTHROCYTOSIS AMONG HIGH ALTITUDE DWELLERS IN CERRO DE PASCO, PERU
10-0095Karam, Sana
RTOG 0920 A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
07-1207Kavanagh, Brian
PHASE I & II STUDY OF STEREOTACTIC BODY RADIATION THERAPY (SBRT) FOR LOW AND INTERMEDIATE RISK PROSTATE CANCER
08-0397Kavanagh, Brian
RTOG 0538 PHASE III COMPARISON OF THORACIC RADIOTHERAPY REGIMENS IN PATIENTS WITH LIMITED SMALL CELL LUNG CANCER ALSO RECEIVING CISPLATIN OR CARBOPLATIN AND ETOPOSIDE
08-1383Kavanagh, Brian
A PHASE III TRIAL OF SHORT TERM ANDROGEN DEPRIVATION WITH PELVIC LYMPH NODE OR PROSTATE BED ONLY RADIOTHERAPY (SPPORT) IN PROSTATE CANCER PATIENTS WITH A RISING PSA AFTER RADICAL PROSTATECTOMY RTOG 0534
10-0876Kavanagh, Brian
RANDOMIZED PHASE II STUDY COMPARING PROPHYLACTIC CRANIAL IRRADIATION ALONE TO PROPHYLACTIC CRANIAL IRRADIATION AND CONSOLIDATIVE EXTRA-CRANIAL IRRADIATION FOR EXTENSIVE DISEASE SMALL CELL LUNG CANCER 9ED-SCLC) RTOG 0937
10-1101Kavanagh, Brian
RTOG 0815: A PHASE III PROSPECTIVE RANDOMIZED TRIAL OF DOSE-ESCALATED RADIOTHERAPY WITH OR WITHOUT SHORT-TERM ANDROGEN DEPRIVATION THERAPY FOR PATIENTS WITH INTERMEDIATE-RISK PROSTATE CANCER
01-279Keith, Robert
A RANDOMIZED PHASE II CHEMOPREVENTION STUDY OF ILOPROST VERSUS PLACEBO IN PATIENTS AT HIGH RISK FOR LUNG CANCER
08-0715Keith, Robert
A RANDOMIZED PHASE II CHEMOPREVENTION STUDY OF PIOGLITAZONE VERSUS PLACEBO IN PATIENTS AT HIGH RISK FOR LUNG CANCER
06-0124Kinsella, John
NON-INVASIVE INHALED NITRIC OXIDE IN PREMATURE NEWBORNS
10-0771Kluger, Benzi
COGNITIVE DYSFUNCTION IN PARKINSON'S DISEASE
00-236Kounalakis, Nicole
NSABP B-31 A RANDOMIZED TRIAL COMPARING THE SAFETY AND EFFICACY OF ADRIAMYCIN AND CYCLOPHOSPHAMIDE FOLLOWED BY TAXOL (AC-T) TO THAT OF ADRIAMYCIN AND CYCLOPHOSPHAMIDE FOLLOWED BY TAXOL PLUS HERCEPTIN (AC-T+H) IN NODE-POSITIVE BREAST CANCER PATIENTS WHO HAVE TUMORS THAT OVEREXPRESS HER2
06-0943Kounalakis, Nicole
A CLINICAL TRIAL TO DETERMINE THE EFFICACY OF FIVE YEARS OF LETROZOLE COMPARED TO PLACEBO IN PATIENTS COMPLETING FIVE YEARS OF HORMONAL THERAPY CONSISTING OF AN AROMATASE INHIBITOR (AI) OR TAMOXIFEN FOLLOWED BY AN AI IN PROLONGING DISEASE FREE SURVIVAL IN POST MENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE BREAST CANCER
07-0635Kounalakis, Nicole
RANDOMIZED PHASE III TRIAL OF NEOADJUVANT THERAPY FOR PATIENTS WITH PALPABLE AND OPERABLE HER2 POSITIVE BREAST CANCER COMPARING THE COMBINATION OF TRASTUZUMAB PLUS LAPATINIB TO TRASTUZUMAB AND TO LAPATINIB ADMINISTERED WITH WEEKLY PACLITAXEL FOLLOWING AC ACCOMPANIED BY CORRELATIVE SCIENCE STUDIES TO IDENTIFY PREDICTORS OF PATHOLOGIC COMPLETE RESPONSE
08-1266Kounalakis, Nicole
A PHASE III CLINICAL TRIAL COMPARING TRASTUZUMAB GIVEN CONCURRENTLY WITH RADIATION THERAPY AND RADIATION THERAPY ALONE FOR WOMEN WITH HER2-POSITIVE DUCTAL CARCINOMA IN SITU RESECTED BY LUMPECTOMY
10-1234Krebs, Nancy
Iron Deficiency in Infants and Toddlers: Does Vitamin E Enhance Efficacy of Iron Treatment?
10-0519Leong, Stephen
S0518:Phase III Prospective Randomized Comparison of Depot Octreotide Plus Interferon Alpha Versus Depot Octreotide Plus Bevacizumab (NSC#704865) In advanced, Poor Carcinoid Patients
10-1455Leong, Stephen
CALGB C80702, A Phase III Trial of Versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
10-1461Levin, Myron
Safety, Tolerability and Immunogenicity of a Booster Dose of Zostavax Administered >= 10 Years After a First Dose Compared with a First Dose of Zostavax
09-0352Macy, Margaret
A PHASE II STUDY OF EXTERNAL BEAM RADIATION THERAPY AND CETUXIMAB FOLLOWED BY IRINOTECAN AND CETUXIMAB FOR CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED DIFFUSE PONTINE TUMORS AND HIGH GRADE ASTROCYTOMAS (POE08-01)
09-0814Macy, Margaret
A Phase II Study of Everolimus (RAD001) for Children with Chemotherapy and/or Radiation-Refractory Progressive or Recurrent Low-Grade Gliomas
10-0418Macy, Margaret
The Role of Bevacizumab in the Treatment of Radiation Induced Injury/Radiation Necrosis in Children with Central Nervous System Tumors
06-1151Madden, Jennifer
FEASIBILITY OF USING CONCURRENT CARBOPLATIN AND REDUCED DOSE CRANIOSPINAL RADIATION (24 GY) FOR METASTATIC MEDULLOBLASTOMA AND HIGH-RISK SUPRATENTORIAL PNET AND METASTATIC PNET
08-0312Maloney, Kelly
AALL07P2 PHARMACOLOGY AND TOXICITY OF ERWINIA ASPARAGINASE (ERWINASE®; CRISANTASPASE; IND 290) FOLLOWING ALLERGY TO PEG-ASPARAGINASE IN TREATMENT OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
10-1220Manco-Johnson, Marilyn
Inhibitor Development in Previously Untreated Patient (pups) or Minimally blood component Treated Patients (Mbctp) when Exposed to Plasma-Derived Von Willebrand Factor-containing Factor Viii (Vw/Fviii) Concentrates and to Recombinant Factor Viii (Rfviii) Concentrates: An Independent, International, Multi-center, Prospective, Controlled Randomized, Open Label, Clinical Trial (Sippet)
07-0182Maroni, Paul
RANDOMIZED PHASE III STUDY OF NEO-ADJUVANT DOCETAXEL AND ANDROGEN DEPRIVATION PRIOR TO RADICAL PROSTATECTOMY VS IMMEDIATE RADICAL PROSTATECTOMY IN PATIENTS WITH HIGH RISK CLINICALLY LOCALIZED PROSTATE CANCER.
11-0050Martiniano, Stacey
Compassionate use of Clofazimine (Lamprene®) - CCC
02-607McCarter, Martin
ACOSOG Z9001: A PHASE III RANDOMIZED DOUBLE-BLIND STUDY OF ADJUVANT STI571 (GLEEVEC) VERSUS PLACEBO IN PATIENTS FOLLOWING THE RESECTION OF PRIMARY GASTROINTESTINAL STROMAL TUMOR (GIST)
06-0703McCarter, Martin
A CLINICAL TRIAL COMPARING PREOPERATIVE RADIATION THERAPY AND CAPECITABINE WITH OR WITHOUT OXALIPLATIN WITH PREOPERATIVE RADIATION THERAPY AND CONTINUOUS INTRAVENOUS INFUSION OF 5-FLUOROURACIL WITH OR WITHOUT OXALIPLATIN IN THE TREATMENT OF PATIENTS WITH OPERABLE CARCINOMA OF THE RECTUM.--NSABP PROTOCOL R-04 IND
09-0562McCarter, Martin
PHASE II, NON-RANDOMIZED, OPEN-LABEL MULTICENTER STUDY OF 5 YEAR ADJUVANT IMATINIB MESYLATE (GLEEVEC) IN PATIENTS AT SIGNIFICANT RISK FOR RECURRENCE FOLLOWING COMPLETE RESECTION OF PRIMARY GASTROINTESTINAL STROMAL TUMOR (GIST)
03-546McFarland, Elizabeth
IMPAACT P1026s: Pharmacokinetic Properties of Antiretroviral and Related Drugs During Pregnancy and Postpartum, Version 9.0
10-1504McFarland, Elizabeth
1077HS HAART Standard Version of the PROMISE Study (Promoting Maternal and Infant Survival Everywhere), Version 2.0
05-0941Messersmith, Wells
SWOG C80405 A PHASE III TRIAL OF IRINOTECAN/5-FU/LEUCOVORIN OR OXALIPLATIN/5-FU/LEUCOVORIN WITH BEVACIZUMAB, OR CETUXIMAB (C225), FOR PATIENTS WITH UNTREATED METASTATIC ADENOCARCINOMA OF THE COLON OR RECTUM
05-1014Messersmith, Wells
SWOG E5202, A RANDOMIZED PHASE III STUDY COMPARING 5-FU, LEUCOVORIN AND OXALIPLATIN VS. 5-FU, LEUCOVORIN, OXALIPLATIN AND BEVACIZUMAB IN PATIENTS WITH STAGE II COLON CANCER AT HIGH RISK FOR RECURRENCE TO DETERMINE PROSPECTIVELY THE PROGNOSTIC VALUE OF MOLECULAR MARKERS
07-0855Messersmith, Wells
N0147, A RANDOMIZED PHASE III TRIAL OF OXALIPLATIN (OXAL) PLUS 5 FLUOROURACIL (5-FU) / LEUCOVORIN (CF) WITH OR WITHOUT CETUXIMAB (C225) AFTER CURATIVE RESECTION FOR PATIENTS WITH STAGE III COLON CANCER
00-979Moore, Ernest
Preoperative Hypertonic Saline Attenuates Postoperative PMN Priming Following Major Elective Surgery
06-0537Moreau, Kerrie
BIOLOGICAL MECHANISMS OF VASCULAR DYSFUNCTION WITH AGE AND ESTROGEN DEFICIENCY
09-0272Parsons, Julie
A PHASE 2B EXTENSION STUDY OF PTC124 IN SUBJECTS WITH NONSENSE-MUTATION-MEDIATED DUCHENNE AND BECKER MUSCULAR DYSTROPHY.
10-1425Parsons, Julie
An Open-label, Safety Study for Previously Treated Ataluren (Ptc124) Patients with Nonsense Mutation Dystrophinopathy
07-0074Patel, Vikas
CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF THE AESCULAP ACTIV-L ARTIFICIAL DISC IN THE TREATMENT OF DEGENERATIVE DISC DISEASE
08-0786Polotsky, Alex
PREGNANCY IN POLYCYSTIC OVARY SYNDROME II (PPCOS II): A 25-WEEK, DOUBLE-BLINDED, RANDOMIZED TRIAL OF CLOMIPHENE CITRATE AND LETROZOLE FOR THE TREATMENT OF INFERTILITY IN WOMEN WITH POLYCYSTIC OVARY SYNDROME THE PURPOSE OF THIS STUDY IS TO DETERMINE WHICH OF THESE TWO MEDICATIONS, CLOMIPHENE CITRATE (CLOMID) OR LETROZOLE (FEMARA), WILL MOST LIKELY RESULT IN PREGNANCY AND A LIVE BIRTH IN WOMEN WITH PCOS
10-0547Polotsky, Alex
ASSESSMENT OF MULTIPLE INTRAUTERINE GESTATIONS FROM OVARIAN STIMULATION
07-0677Purcell, William
CTSU/E1505 - A PHASE III RANDOMIZED TRIAL OF ADJUVANT CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB FOR COMPLETELY RESECTED STAGE IB-IIIA NON-SMALL CELL LUNG CANCER.
10-1453Purtle, Steven
Evaluation Of Two Plasma Transfusion Strategies In Bleeding Critically Ill Patients With Chronic Liver Disease
02-182Rabinovitch, Rachel
RTOG 96-01 A PHASE III TRIAL OF RADIATION THERAPY WITH OR WITHOUT CASODEX IN PATIENTS WITH PSA ELEVATION FOLLOWING RADICAL PROSTATECTOMY FOR PT3NO CARCINOMA OF THE PROSTATE.
04-0991Rabinovitch, Rachel
RTOG 0234 - A PHASE II RANDOMIZED TRIAL OF SURGERY FOLLOWED BY CHEMORADIOTHERAPY PLUS C225 (CETUXIMAB) FOR ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
06-0829Rabinovitch, Rachel
RTOG 0417: A PHASE II STUDY OF BEVACIZUMAB IN COMBINATION WITH DEFINITIVE RADIOTHERAPY AND CISPLATIN CHEMOTHERAPY IN UNTREATED PATIENTS WITH LOCALLY ADVANCED CERVICAL CARCINOMA
10-0644Rasouli, Neda
Exscel (exenatide study of cardiovascular event lowering trial): a randomized, placebo controlled clinical trial to evaluate cardiovascular outcomes after treatment with exenatide once weekly in patients with type 2 diabetes mellitus
10-1191Rasouli, Neda
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results a Long-Term, Multi-Centre, International, Randomized Double-Blind, Placebo-Controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
10-0438Regensteiner, Judith
IMPACT OF EXENATIDE ON CARDIOVASCULAR EXERCISE PERFORMANCE IN TYPE 2 DIABETES
04-0567Ringel, Steven
Use Of 3,4-Diaminopyridine (3,4-Dap) In The Treatment Of Lambert-Eaton Syndrome (Lems)
04-0678Ross, Randal
DOUBLE-BLIND TRIAL OF CHOLINE DURING PREGNANCY AND RISK FOR SCHIZOPHRENIA
10-1393Schauer, Irene
EFFECTS OF SERUM FATTY ACID LOWERING ON INSULIN SENSITIVITY, CARDIOVASCULAR FUNCTION, AND EXERCISE CAPACITY IN NON-INSULIN DEPENDENT DIABETES
02-744Schrier, Robert
EFFICACY OF AGGRESSIVE RENIN-ANGIOTENSIN-ALDOSTERONE AXIS BLOCKADE IN PREVENTING/SLOWING RENAL FUNCTION DECLINE IN ADPKD
07-1215Schwartz, Robert
Pioglitazone and Exercise Effects on Older Adults with Mild Cognitive Impairment and Metabolic Syndrome
05-0407Sokol, Ronald
A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL OF CORTICOSTEROID THERAPY FOLLOWING PORTOENTEROSTOMY IN INFANTS WITH BILIARY ATRESIA
06-1084Steck, Andrea
ORAL INSULIN FOR PREVENTION OF DIABETES IN PATIENTS AT RISK FOR TYPE 1 DIABETES
09-1203Sundaram, Shikha
Ursodeoxycholic Acid (UDCA) Therapy Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
10-0753Taylor, Matthew
Gzgd02607: A Phase 3, Randomized, Multi-Center, Multi-National, Open-Label, Active Comparator Study to Evaluate the Efficacy and Safety of GENZ-112638 in Patients With Gaucher Disease Type 1 who have Reached Therapeutic Goals with Enzyme Replacement Therapy (ENCORE)
10-0013Teal, Stephanie
A Multi-center, Open-Label, Randomized Parallel Group Study to Evaluate the Effects on the Mechanisms of Contraceptive Efficacy and, Secondarily, to Assess the Pharmacokinetic Profile and Safety of Two Progestin-Only Patches Containing Different Doses of Levonorgestrel (LNG) CCN009
08-1376Van Hove, Johan
OXIDATIVE STRESS MARKERS IN INHERITED HOMOCYSTINURIA AND THE IMPACT OF TAURINE
10-1143Vollmer, Timothy
A Phase II, Double Blinded, Active Comparator, Randomized, Five Year Study Comparing Rituximab Induction Therapy Followed By Glatiramer Acetate Therapy to Glatiramer Acetate Monotherapy In Patients With Relapsing Multiple Sclerosis
03-585Wang, Michael
PROSPECTIVE MULTICENTER EVALUATION OF THE DURATION OF THERAPY FOR THROMBOSIS IN CHILDREN
10-0314Weekes, Colin
A PHASE III STUDY OF CHEMOTHERAPY AND CHEMORADIOTHERAPY WITH OR WITHOUT HYPERACUTE® - PANCREAS (ALGENPANTUCEL-L) IMMUNOTHERAPY IN SUBJECTS WITH SURGICALLY RESECTED PANCREATIC CANCER
10-0835Weisz, Keith
Comparison of Ketamine v Co-Administration and Propofol for Procedural Sedation in a Pediatric Emergency Department
03-595Zeitler, Philip
TREATMENT OPTIONS FOR TYPE 2 DIABETES IN ADOLESCENTS AND YOUTH